Phase II study of topotecan (TPT) 21-day infusion in platinum-treated ovarian cancer: a highly active regimen. (a NYGOG study). - Hochster,H.; Speyer,J.; Wadler,S. (Proc Am Soc Clin Oncol, 1996)